Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities And Strategies To 2034

Description

Induced pluripotent stem cells (iPSC), are a type of artificial stem cells that are pluripotent, which can give rise to several different cell types, but are produced directly from somatic cells.

The induced pluripotent stem cell (IPSC) market consists of the sales of induced pluripotent stem cell (IPSC) by entities (organizations, sole traders, and partnerships) that are derived from adult somatic cells such as fibroblasts or blood cells that have been reprogrammed into pluripotent stem cells by the introduction of a set of transcription factors linked to pluripotency. The resulting iPSCs can then be differentiated into a variety of cell types, such as cardiomyocytes, neuronal cells, hepatocytes and hematopoietic cells, using in vitro differentiation protocols.

The global induced pluripotent stem cell (IPSC) market was valued at $1,178.05 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 10.00%.

Rising Prevalence Of Genetic Disorders

During the historic period, the rising prevalence of genetic disorders supported the growth of the induced pluripotent stem cell (iPSC) market. The rising prevalence of genetic disorders has heightened the need for advanced models to study these conditions. iPSCs enable the creation of patient-specific models, accelerating research into diseases like cystic fibrosis and Duchenne muscular dystrophy. Additionally, iPSCs serve as a platform for gene editing technologies, such as CRISPR-Cas9, offering potential treatments for genetic disorders. With their ability to generate healthy tissues, iPSCs are becoming increasingly important in regenerative medicine, particularly for treating degenerative conditions and organ dysfunction. For instance, in February 2023, according to an article published by Genetic Alliance UK, according to estimates, the genetic condition affects 1 in every 25 children. This implies that 30,000 babies and children are newly diagnosed in the UK annually and more than 2.4 million children and adults have a genetic disorder. Therefore, the rising prevalence of genetic disorders drove the growth of the induced pluripotent stem cell (iPSC) market.

Innovative iPSC-Based Cancer Therapy Moves Forward With Significant Investment

Major companies operating in the induced pluripotent stem cell (iPSC) market are strategically investing by focusing on the development of advanced cell culture systems and tools to improve iPSC generation, differentiation and characterization processes. They are actively working on optimizing production methods for higher efficiency and scalability, addressing challenges in regulatory compliance and developing new applications in drug discovery, regenerative medicine and disease modeling. For example, in August 2024, Shinobi Therapeutics, a US-based biotechnology company pioneering the development of off-the-shelf, immune-evasive cell therapies derived from induced pluripotent stem cells (iPSCs), secured a non-dilutive grant of up to $59 million from the Japanese Agency for Medical Research and Development (AMED) to advance its lead iPS-T cell therapy targeting GPC3-positive solid tumors. This funding will support the development of Shinobi's immune-evasive iPSC-derived T cell therapies, which aim to provide scalable, off-the-shelf treatments for cancer patients.

The global induced pluripotent stem cell (iPSC) market is fairly concentrated, with large number of small players operating in the market. The top ten competitors in the market made up to 30.52% of the total market in 2023.

Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global induced pluripotent stem cells (iPSC) market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for induced pluripotent stem cells (iPSC)? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The induced pluripotent stem cells (iPSC) market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider induced pluripotent stem cells (iPSC) market; and compares it with other markets.

The report covers the following chapters

Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by derived cell type, by application and by end-user.
Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
Global Market Size And Growth- Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
Market Segmentation - Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by derived cell type, by application and by end-user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
Recent Developments- Information on recent developments in the market covered in the report.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for induced pluripotent stem cells (iPSC) providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Derived Cell Type: Hepatocytes; Fibroblasts; Keratinocytes; Amniotic Cells; Other Derived Cell Types
2) By Application: Academic Research; Drug Discovery And Toxicity Studies; Regenerative Medicine; Cell And Gene Therapy
3) By End-User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Other End Users
Companies Mentioned: FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc); Thermo Fisher Scientific Inc.; STEMCELL Technologies Inc.; Lonza Group AG; Miltenyi Biotec GmbH
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; induced pluripotent stem cells (iPSC) indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Product Code: o&s1695

1 Executive Summary

1.1 Induced Pluripotent Stem Cell (iPSC) - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition
6.2 Summary
6.3 Induced Pluripotent Stem Cell (iPSC) Market Definition And Segmentations
6.4 Market Segmentation By Derived Cell Type
- 6.4.1 Hepatocytes
- 6.4.2 Fibroblasts
- 6.4.3 Keratinocytes
- 6.4.4 Amniotic Cells
- 6.4.5 Other Derived Cell Types
6.5 Market Segmentation By Application
- 6.5.1 Academic Research
- 6.5.2 Drug Discovery And Toxicity Studies
- 6.5.3 Regenerative Medicine
- 6.5.4 Cell And Gene Therapy
6.6 Market Segmentation By End-User
- 6.6.1 Academic And Research Institutes
- 6.6.2 Pharmaceutical And Biotechnology Companies
- 6.6.3 Other End Users

7 Major Market Trends

7.1 Ready-To-Use iPSC Cell Lines Pave Way For Off-The-Shelf Cell Therapies
7.2 Innovative iPSC-Based Cancer Therapy Moves Forward With Significant Investment
7.3 Standardized iPSC Lines Enhance Efficiency In Therapeutic Development
7.4 Strategic Partnership Targets Commercialization Of Gene-Edited iPSCs
7.5 Advancing CNS Drug Development With Human iPSC-Based BBB Models

8 Global Induced Pluripotent Stem Cell (iPSC) Growth Analysis And Strategic Analysis Framework

8.1 Global: PESTEL Analysis
- 8.1.1 Political
- 8.1.2 Economic
- 8.1.3 Social
- 8.1.4 Technological
- 8.1.5 Environmental
- 8.1.6 Legal
8.2 Analysis Of End Use Industries (B2B)
- 8.2.1 Pharmaceutical And Biotechnology Companies
- 8.2.2 Academic And Research Institutes
- 8.2.3 Other End Users
8.3 Global Induced Pluripotent Stem Cell (iPSC) Market Growth Rate Analysis
8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
- 8.4.1 Market Drivers 2019 - 2024
- 8.4.2 Market Restraints 2019 - 2024
8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
8.6 Forecast Growth Contributors/Factors
- 8.6.1 Quantitative Growth Contributors
- 8.6.2 Drivers
- 8.6.3 Restraints
8.7 Global Induced Pluripotent Stem Cell (iPSC) Total Addressable Market (TAM)

9 Global Induced Pluripotent Stem Cell (iPSC) Market Segmentation

9.1 Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.2 Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.3 Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.4 Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation Of Hepatocytes, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.5 Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation Of Fibroblasts, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.6 Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation Of Keratinocytes, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.7 Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation By Amniotic Cells, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.8 Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation By Other Derived Cells, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Induced Pluripotent Stem Cell (iPSC) Market, Regional and Country Analysis

10.1 Global Induced Pluripotent Stem Cell (iPSC) Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.2 Global Induced Pluripotent Stem Cell (iPSC) Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

11.1 Summary
11.2 Market Overview
- 11.2.1 Region Information
- 11.2.2 Market Information
- 11.2.3 Background Information
- 11.2.4 Government Initiatives
- 11.2.5 Regulations
- 11.2.6 Regulatory Bodies
- 11.2.7 Major Associations
- 11.2.8 Taxes Levied
- 11.2.9 Corporate Tax Structure
- 11.2.10 Investments
- 11.2.11 Major Companies
11.3 Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.4 Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.5 Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.6 Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
11.7 China Market
11.8 Summary
11.9 Market Overview
- 11.9.1 Country Information
- 11.9.2 Market Information
- 11.9.3 Background Information
- 11.9.4 Government Initiatives
- 11.9.5 Regulations
- 11.9.6 Regulatory Bodies
- 11.9.7 Major Associations
- 11.9.8 Taxes Levied
- 11.9.9 Corporate Tax Structure
- 11.9.10 Investments
- 11.9.11 Major Companies
11.10 China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.11 China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.12 China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.13 India Market
11.14 India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.15 India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.16 India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.17 Japan Market
11.18 Summary
11.19 Market Overview
- 11.19.1 Country Information
- 11.19.2 Market Information
- 11.19.3 Background Information
- 11.19.4 Government Initiatives
- 11.19.5 Regulations
- 11.19.6 Regulatory Bodies
- 11.19.7 Major Associations
- 11.19.8 Taxes Levied
- 11.19.9 Corporate Tax Structure
- 11.19.10 Investments
- 11.19.11 Major Companies
11.20 Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.21 Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.22 Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.23 South Korea Market
11.24 Summary
11.25 Market Overview
- 11.25.1 Country Information
- 11.25.2 Market Information
- 11.25.3 Background Information
- 11.25.4 Government Initiatives
- 11.25.5 Regulations
- 11.25.6 Regulatory Bodies
- 11.25.7 Major Associations
- 11.25.8 Taxes Levied
- 11.25.9 Corporate Tax Structure
- 11.25.10 Investments
- 11.25.11 Major Companies
11.26 South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.27 South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.28 South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.29 Australia Market
11.30 Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.31 Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.32 Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.33 Indonesia Market
11.34 Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.35 Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.36 Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

12.1 Summary
12.2 Market Overview
- 12.2.1 Region Information
- 12.2.2 Market Information
- 12.2.3 Background Information
- 12.2.4 Government Initiatives
- 12.2.5 Regulations
- 12.2.6 Regulatory Bodies
- 12.2.7 Major Associations
- 12.2.8 Taxes Levied
- 12.2.9 Corporate tax structure
- 12.2.10 Investments
- 12.2.11 Major Companies
12.3 Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.4 Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.5 Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.6 Western Europe Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
12.7 UK Market
12.8 UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.9 UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.10 UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.11 Germany Market
12.12 Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.13 Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.14 Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.15 France Market
12.16 France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.17 France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.18 France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.19 Italy Market
12.20 Italy Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.21 Italy Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.22 Italy Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.23 Spain Market
12.24 Spain Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.25 Spain Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.26 Spain Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

13.1 Summary
13.2 Market Overview
- 13.2.1 Region Information
- 13.2.2 Market Information
- 13.2.3 Background Information
- 13.2.4 Government Initiatives
- 13.2.5 Regulations
- 13.2.6 Regulatory Bodies
- 13.2.7 Major Associations
- 13.2.8 Taxes Levied
- 13.2.9 Corporate Tax Structure
- 13.2.10 Investments
- 13.2.11 Major Companies
13.3 Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.4 Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.5 Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.6 Russia Market
13.7 Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.8 Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.9 Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

14.1 Summary
14.2 Market Overview
- 14.2.1 Region Information
- 14.2.2 Market Information
- 14.2.3 Background Information
- 14.2.4 Government Initiatives
- 14.2.5 Regulations
- 14.2.6 Regulatory Bodies
- 14.2.7 Major Associations
- 14.2.8 Taxes Levied
- 14.2.9 Corporate Tax Structure
- 14.2.10 Investments
- 14.2.11 Major Companies
14.3 North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.4 North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.5 North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.6 USA Market
14.7 Summary
14.8 Market Overview
- 14.8.1 Country Information
- 14.8.2 Market Information
- 14.8.3 Background Information
- 14.8.4 Government Initiatives
- 14.8.5 Regulations
- 14.8.6 Regulatory Bodies
- 14.8.7 Major Associations
- 14.8.8 Taxes Levied
- 14.8.9 Corporate Tax Structure
- 14.8.10 Investments
- 14.8.11 Major Companies
14.9 USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.10 USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.11 USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.12 Canada Market
14.13 Summary
14.14 Market Overview
- 14.14.1 Country Information
- 14.14.2 Market Information
- 14.14.3 Background Information
- 14.14.4 Government Initiatives
- 14.14.5 Regulations
- 14.14.6 Regulatory Bodies
- 14.14.7 Major Associations
- 14.14.8 Taxes Levied
- 14.14.9 Corporate Tax Structure
- 14.14.10 Investments
- 14.14.11 Major Companies
14.15 Canada Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.16 Canada Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.17 Canada Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

15.1 Summary
15.2 Market Overview
- 15.2.1 Region Information
- 15.2.2 Market Information
- 15.2.3 Background Information
- 15.2.4 Government Initiatives
- 15.2.5 Regulations
- 15.2.6 Regulatory Bodies
- 15.2.7 Major Associations
- 15.2.8 Taxes Levied
- 15.2.9 Corporate Tax Structure
- 15.2.10 Investments
- 15.2.11 Major Companies
15.3 South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.4 South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.5 South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.6 Brazil Market
15.7 Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.8 Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.9 Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

16.1 Summary
16.2 Market Overview
- 16.2.1 Region Information
- 16.2.2 Market Information
- 16.2.3 Background Information
- 16.2.4 Government Initiatives
- 16.2.5 Regulations
- 16.2.6 Regulatory Bodies
- 16.2.7 Major Associations
- 16.2.8 Taxes Levied
- 16.2.9 Corporate Tax Structure
- 16.2.10 Investments
- 16.2.11 Major Companies
16.3 Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.4 Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.5 Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

17.1 Summary
17.2 Market Overview
- 17.2.1 Region Information
- 17.2.2 Market Information
- 17.2.3 Background Information
- 17.2.4 Government Initiatives
- 17.2.5 Regulations
- 17.2.6 Regulatory Bodies
- 17.2.7 Major Associations
- 17.2.8 Taxes Levied
- 17.2.9 Corporate Tax Structure
- 17.2.10 Major Companies
17.3 Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.4 Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.5 Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

18.1 Company Profiles
18.2 FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc).
- 18.2.1 Company Overview
- 18.2.2 Products And Services
- 18.2.3 Business Strategy
- 18.2.4 Financial Overview
18.3 Thermo Fisher Scientific Inc.
- 18.3.1 Company Overview
- 18.3.2 Products And Services
- 18.3.3 Business Strategy
- 18.3.4 Financial Overview
18.4 STEMCELL Technologies Inc.
- 18.4.1 Company Overview
- 18.4.2 Products And Services
- 18.4.3 Business Strategy
- 18.4.4 Financial Overview
18.5 Lonza Group AG
- 18.5.1 Company Overview
- 18.5.2 Products And Services
- 18.5.3 Financial Overview
18.6 Miltenyi Biotec GmbH
- 18.6.1 Company Overview
- 18.6.2 Products And Services
- 18.6.3 Financial Overview

19 Other Major Companies

19.1 Takara Bio Inc.
- 19.1.1 Company Overview
- 19.1.2 Products And Services
19.2 Astellas Pharma Inc.
- 19.2.1 Company Overview
- 19.2.2 Products And Services
19.3 Fate Therapeutics Inc.
- 19.3.1 Company Overview
- 19.3.2 Products And Services
19.4 ViaCyte Inc.
- 19.4.1 Company Overview
- 19.4.2 Products And Services
19.5 Sartorius
- 19.5.1 Company Overview
- 19.5.2 Products And Services
19.6 Shanghai Cell Therapy Group Ltd.
- 19.6.1 Company Overview
- 19.6.2 Products And Services
19.7 Ncardia
- 19.7.1 Company Overview
- 19.7.2 Products And Services
19.8 REPROCELL USA Inc.
- 19.8.1 Company Overview
- 19.8.2 Products And Services
19.9 Applied StemCells Inc.
- 19.9.1 Company Overview
- 19.9.2 Products And Services
19.10 Treefrog Therapeutics Inc.
- 19.10.1 Company Overview
- 19.10.2 Products And Services
19.11 Japan Tissue Engineering Co. Ltd.
- 19.11.1 Company Overview
- 19.11.2 Products And Services
19.12 DefiniGEN
- 19.12.1 Company Overview
- 19.12.2 Products And Services
19.13 Merck KGaA.
- 19.13.1 Company Overview
- 19.13.2 Products And Services
19.14 iXCells Biotechnologies Inc.
- 19.14.1 Company Overview
- 19.14.2 Products And Services
19.15 Cynata Therapeutics Limited
- 19.15.1 Company Overview
- 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

22.1 Shineco Acquired InfiniClone Ltd
22.2 Axol Bioscience Ltd Acquired Phenocell SAS
22.3 Century Therapeutics Acquired Clade Therapeutics
22.4 QHP Capital Acquired Applied StemCell
22.5 Vertex Pharmaceuticals Acquired ViaCyte
22.6 Medipost Acquired OmniaBio

23 Recent Developments In The Induced Pluripotent Stem Cell (iPSC) Market

23.1 Revolutionary Stem Cell Banking Brings Personalized Regenerative Care To The Masses
23.2 Next-Generation NK Cell Therapy Platform Enhances Clinical Readiness
23.3 Revolutionizing Cardiovascular Care With Personalized iPSC Solutions
23.4 AI-Powered iPSC Foundry Improving Outcomes For Parkinson's Patients

24 Opportunities And Strategies

24.1 Global Induced Pluripotent Stem Cell (iPSC) Market In 2029 - Countries Offering Most New Opportunities
24.2 Global Induced Pluripotent Stem Cell (iPSC) Market In 2029 - Segments Offering Most New Opportunities
24.3 Global Induced Pluripotent Stem Cell (iPSC) Market In 2029 - Growth Strategies
- 24.3.1 Market Trend Based Strategies
- 24.3.2 Competitor Strategies

25 Induced Pluripotent Stem Cell (iPSC) Market, Conclusions And Recommendations

25.1 Conclusions
25.2 Recommendations
- 25.2.1 Product
- 25.2.2 Place
- 25.2.3 Price
- 25.2.4 Promotion
- 25.2.5 People

26 Appendix

26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 The Business Research Company
26.6 Copyright and Disclaimer